Skip to content
healthcare.dev
Get a free key

Tecentriq Hybreza

NDC 50242-933, atezolizumab and hyaluronidase-tqjs, injection, from Genentech, Inc..

Product NDC
50242-933
Status
Listed
Labeler
Genentech, Inc.
Dosage form
INJECTION
Route
SUBCUTANEOUS
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
BLA
Application
BLA761347
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/50242-933 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • ATEZOLIZUMAB1875 mg/15mL
  • HYALURONIDASE (HUMAN RECOMBINANT)30000 U/15mL

Pharmacologic classes

Antibodies [CS]; Antibodies, Monoclonal [CS]; Antibodies, Monoclonal, Humanized [CS]; Endoglycosidase [EPC]; Glycoside Hydrolases [CS]; Programmed Death Receptor-1 Blocking Antibody [EPC]; Programmed Death Receptor-1-directed Antibody Interactions [MoA]

Package NDCNDC-11Package
50242-933-01502420933011 VIAL, SINGLE-DOSE in 1 BOX (50242-933-01) / 15 mL in 1 VIAL, SINGLE-DOSE
50242-933-86502420933861 VIAL, SINGLE-DOSE in 1 BOX (50242-933-86) / 15 mL in 1 VIAL, SINGLE-DOSE

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/a617b089-ce66-464b-987b-b45d029b4d6f

  • Medicare Part B payment limits (ASP)

    GET /v1/drugs/asp?ndc=50242-933

Use it

Look up 50242-933 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/50242-933 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 50242-933. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Get a free keyNDC docsConnect the MCP server

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.